IntelliPharmaCeutics drug delivery technology licensing program is particularly suited to the requirements of owners of new chemical entities (NCE's) whose short half lives make multiple dosing per day necessary. IntelliPharmaCeutics' proprietary technologies offer the means to add new dimensions to these products by enabling their once a day delivery

For more information contact Yogish Kamath, Director of New Business Development at ykamath@intellipharmaceutics.com